<DOC>
	<DOC>NCT00479713</DOC>
	<brief_summary>This is a multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus rosuvastatin in participants with high cholesterol.</brief_summary>
	<brief_title>A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe, Simvastatin Drug Combination</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Participant is currently taking a statin medication for the treatment of high cholesterol Participant has an LDLC level that is greater than or equal to 100 mg/dl and less than or equal to 190 mg/dl Women who are pregnant or nursing, or women who intend to become pregnant Participant has any condition, situation, or is currently taking any medication that might pose a risk to the participant or interfere with participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>High Cholesterol</keyword>
</DOC>